Balyasny Asset Management »

Bright Minds Biosciences shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $11M 187k 60.66

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Select Sector Spdr Tr Financial (XLF)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Visa Com Cl A Call Option (V)
Wolfspeed Common Stock (WOLF)

View all positions for Balyasny Asset Management

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
Vivo Capital
Commodore Capital
Perceptive Advisors
Adage Capital Partners GP
Braidwell
BlackRock
Sio Capital Management
Balyasny Asset Management
Morgan Stanley
Point72 Asset Management
Longwood Capital Partners
Millennium Management
Walleye Trading Advisors

View all funds holding Bright Minds Biosciences